Multiple Myeloma Research Foundation (MMRF) Welcomes Michael Reinert to Board of Directors

Michael Reinert, Longtime MMRF Supporter and Multiple Myeloma Patient, Deepens Commitment to Foundation by Joining Board of Directors

Norwalk, CT — June 9, 2011

The Multiple Myeloma Research Foundation (MMRF) today announced that Michael Reinert, a leading music industry attorney who most recently served as Executive Vice President of Business & Legal Affairs for the Universal Motown Republic Group, a division of UMG Recordings, Inc., has joined the Foundation’s Board of Directors. Reinert currently serves as the Chairman of the Entertainment Law Initiative of the Grammy Foundation, a division of the National Academy of Recording Arts and Sciences, which focuses on legal education programs for aspiring entertainment attorneys.

A longtime, dedicated supporter of the MMRF, Reinert recently wrote and starred in his first play, “So Tell Me, What Can I Do?” He developed the acclaimed one-man show while undergoing treatment for multiple myeloma and he generously presented the MMRF with the proceeds from the production. Reinert delivered a moving address as the Courage and Commitment Award Honoree at the MMRF’s Fall Gala in 2010. Reinert is taking an active leadership role in the planning for this year’s event – to be held October 29 in Greenwich, CT – where Stevie Wonder will receive the MMRF Spirit of Hope Award.

“We are delighted to welcome Michael Reinert to the MMRF Board of Directors,” said Kathy Giusti, Founder and CEO of the MMRF and a multiple myeloma patient. “He is committed to helping the MMRF advance the urgent research necessary to develop next-generation treatments and find a cure. We are grateful for all of his dedicated work on our behalf and we are looking forward to his continued involvement in support of our mission.”

Prior to joining Universal, Reinert was the Vice President of Business & Legal Affairs for PolyGram Records, representing the legendary Verve Records label and Mercury Nashville Records. For ten years, Reinert taught Contract Drafting and Negotiation in the Music Industry as an Adjunct Professor of Law at his alma mater, The Benjamin Cardozo School of Law of Yeshiva University. Additionally, he has been a contributing editor to the “Practicing Law Institute”. Reinert served on the Board of Directors of The TJ Martell Foundation for ten years, helping them achieve remarkable success in the fields of leukemia and breast cancer research. He also sits on the Artistic Advisory Counsel of the Naked Angels Theatre Company, a leading non-profit theatre group in New York.

About Multiple Myeloma
Multiple myeloma is an incurable blood cancer. The five-year relative survival rate for multiple myeloma is approximately 38 percent, one of the lowest of all cancers. In 2010, more than 20,000 adults in the United States were estimated to be diagnosed with multiple myeloma and approximately 11,000 people died from the disease.

About the Multiple Myeloma Research Foundation (MMRF)
Multiple Myeloma Research Foundation (MMRF) was established in 1998 as a 501(c)3 non-profit organization by twin sisters Karen Andrews and Kathy Giusti, soon after Kathy's diagnosis with multiple myeloma. The mission of the MMRF is to relentlessly pursue innovative means that accelerate the development of next-generation multiple myeloma treatments to extend the lives of patients and lead to a cure. As the world's number-one private funder of multiple myeloma research, the MMRF has raised over $160 million since its inception to fund nearly 120 laboratories worldwide, including 70 new compounds and approaches in clinical trials and pre-clinical studies and has facilitated 30 clinical trials through its affiliate organization, the Multiple Myeloma Research Consortium (MMRC). As exceptional stewards of its donor’s investments, the MMRF consistently surpasses its peers in fiscal responsibility. For more information about the MMRF, please visit www.themmrf.org.

Multiple Myeloma Research Foundation (MMRF)
Anne Quinn Young